The NET Patient Foundation is pleased to work with companies and businesses large or small and appreciates their support. We offer our corporate partners a unique opportunity to align with a small but national charity which is well established and respected in the community and has a primary focus on improving outcomes for people affected by neuroendocrine cancer.
Your support not only helps patients and families with very complex health and social needs, but can also strengthen corporate image, demonstrate a commitment to social responsibility, build staff morale and promote customer and client relationships.
We will also offer you:
- Help with your Profile and Recognition
- Team Building
- Continuous Involvement
- Our Commitment
The NET Patient Foundation is committed to building lasting partnerships with your company. Our corporate partnership programme aims to develop and nurture long-term, mutually beneficial relationships with our business community.
Please find below a list of our current corporate supporters.
Novartis: £25,551 supporting our data project and patient education meetings
IEL: £15,000 for analyst to work at PHE on our NET data project and our Chapter 10 project in England
Ipsen: £25,344.34 supporting our NET Retreat, NCD, NET Natter initiative and nurse education
Sirtex: £ 5,000 supporting our patient education materials
MERCK: £10,500 towards our new Merkel Cell Carcinoma Project